TriSalus Life Sciences In... (TLSI)
NASDAQ: TLSI
· Real-Time Price · USD
4.98
0.00 (0.00%)
At close: Sep 04, 2025, 11:12 AM
0.00% (1D)
| Bid | 4.89 |
| Market Cap | 189.12M |
| Revenue (ttm) | 35.99M |
| Net Income (ttm) | -31.88M |
| EPS (ttm) | -1.15 |
| PE Ratio (ttm) | -4.33 |
| Forward PE | -43 |
| Analyst | Buy |
| Ask | 4.98 |
| Volume | 7,548 |
| Avg. Volume (20D) | 105,327 |
| Open | 4.94 |
| Previous Close | 4.98 |
| Day's Range | 4.93 - 5.05 |
| 52-Week Range | 3.42 - 5.88 |
| Beta | 0.48 |
About TLSI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TLSI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TLSI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
TriSalus Life Sciences Inc. is scheduled to release its earnings on
Nov 13, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
9 months ago
-10.89%
TriSalus Life Sciences shares are trading lower af...
Unlock content with
Pro Subscription
3 weeks ago · seekingalpha.com
TriSalus Life Sciences, Inc. (TLSI) Q2 2025 Earnings Call TranscriptTriSalus Life Sciences, Inc. (NASDAQ:TLSI ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 AM ET Company Participants David B. Patience - Chief Financial Officer Jeremy Feffer - Corporate Parti...
3 months ago · businesswire.com
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion SystemDENVER--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative deli...